Oct 19, 2026 08:00AM
Jul 30, 2026 07:36AM
Jul 30, 2026 06:59AM
Jul 20, 2026 08:00AM
Apr 30, 2026 07:06AM
Apr 30, 2026 06:59AM
Apr 20, 2026 08:00AM Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
Mar 27, 2026 03:39AM
Feb 27, 2026 06:55AM
Feb 26, 2026 07:36AM
Feb 26, 2026 07:00AM
Feb 17, 2026 08:00AM
Jan 7, 2026 04:01PM
Oct 30, 2025 12:03PM Phathom Pharmaceuticals (PHAT) PT Raised to $20 at Guggenheim
Oct 30, 2025 07:17AM
Oct 30, 2025 07:00AM
Oct 20, 2025 08:00AM
Aug 7, 2025 07:00AM
Aug 7, 2025 06:59AM
Jul 28, 2025 08:00AM
Jun 6, 2025 01:46PM Guggenheim on Phathom Pharmaceuticals (PHAT): 'Our NPV analysis suggests fair value in the $12-14 range'
May 1, 2025 07:06AM
May 1, 2025 07:00AM
Apr 23, 2025 08:00AM
Mar 6, 2025 04:24PM
Mar 6, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 15, 2025 10:00PM Biotech Q4 earnings preview: Goldman Sachs
Nov 7, 2024 08:08AM
Nov 7, 2024 08:00AM
Oct 28, 2024 08:00AM
Aug 8, 2024 04:17PM
Aug 8, 2024 08:05AM
Aug 8, 2024 08:00AM
Jul 29, 2024 07:59AM Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024
May 9, 2024 08:08AM
May 9, 2024 08:00AM
Apr 29, 2024 08:00AM
Mar 7, 2024 09:25AM
Mar 7, 2024 08:00AM
Feb 29, 2024 08:00AM
Nov 9, 2023 09:12AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 13c
Nov 9, 2023 08:00AM
Aug 10, 2023 08:01AM
Jun 19, 2023 09:00PM
Jun 4, 2023 09:00PM
May 26, 2023 09:00PM
May 10, 2023 08:00AM
Mar 9, 2023 09:51PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
Feb 28, 2023 08:00AM

1,234,350 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All